Related Experiment Video

Updated: Aug 15, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning
16:27

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 3, 2010

Negative regulators of cytokine signal transduction

D J Hilton1

  • 1Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Victoria, Australia. hilton@wehi.edu.au

Cellular and Molecular Life Sciences : CMLS
|October 20, 1999
PubMed

Insights

Negative regulators like suppressors of cytokine signalling (SOCS) are crucial for controlling Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathways. This review highlights SOCS proteins and compares them with PIAS and SHP-1 inhibitors.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Cytokine signal transduction is critical in cellular communication and immune responses.
  • Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) are key mediators of cytokine signaling.
  • Recent research highlights the importance of negative regulators in controlling JAK/STAT pathway activity.

Purpose of the Study:

  • To review the key features of Suppressors of Cytokine Signalling (SOCS) proteins.
  • To contrast the inhibitory mechanisms of SOCS proteins with other negative regulators of JAK/STAT signaling.
  • To provide an overview of the emerging roles of negative regulators in cytokine signaling.

Main Methods:

  • Literature review of studies on JAK/STAT signaling and its negative regulators.
  • Comparative analysis of the molecular mechanisms of SOCS, PIAS, and SHP-1 proteins.
  • Synthesis of current knowledge on the function and regulation of these inhibitory proteins.

Main Results:

  • SOCS proteins are a major family of negative regulators of JAK/STAT signaling.
  • PIAS and SHP-1 represent distinct families of inhibitors with unique mechanisms.
  • All three families play crucial roles in fine-tuning cytokine responses and preventing aberrant signaling.

Conclusions:

  • Understanding negative regulators like SOCS, PIAS, and SHP-1 is essential for comprehending JAK/STAT pathway control.
  • These inhibitors offer potential therapeutic targets for inflammatory and autoimmune diseases.
  • Further research into the interplay between these regulators will deepen our understanding of cytokine signaling.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...